Among the biggest challenges in the COVID-19 outbreak is the lack of triangulation of clinical, epidemiologic and immunological information for evidence-based response strategies. CORESMA combines an accelerated ad-hoc outbreak response to address the urgency and a sustainable strategy to serve beyond the current public health threat from COVID-19.

CORESMA aims to immediately generate the most needed clinical and epidemiological data needed for defining targeted public health measures at the national and global level, early enough to become effective during this outbreak. Furthermore, the consortium intends to develop and establish tools and methodologies to improve the global public health preparedness for outbreaks emerging in the future. CORESMA started in April 2020 and will run until March 2023. 

Consortium

The consortium is coordinated by the Helmholtz Centre for Infection Research (HZI), Germany.  Members are European researchers from the Netherlands, Switzerland and Germany, as well as partners from China, Ivory Coast and Nepal.

RIVM colleagues involved are Mirjam Kretzschmar and Mart Stein.

Funding

CORESMA has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003480.